Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

N/ACompletedNCT02034175

Somnarus Inc190 enrolled

Overview

The purpose of this study is to evaluate the accuracy of Somnarus diagnostic technology for diagnosis of sleep apnea in human subjects. This includes evaluation of Somnarus technology in Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA), including Cheyne - Stokes respiration (CSR).

This is a multi- center, open label study to evaluate the accuracy of Somnarus device when compared with overnight polysomnographic measurements. The study includes the following steps: Screening the database or advertising among cardiologists, neurologists, pulmonologists and Ear Nose and Throat (ENT) specialists to identify potential subjects. Initial visit, includes: 1. Consent discussion and signature 2. History, vital signs, and physical exam Night study a. A polysomnogram is conducted and, at the same time, a SomnaPatch device is used. Additional visits If side effects occur, or if the data collection fails, or at the request of the sponsor to repeat the sleep study for further data collection and comparison.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

SCREENING

Masking

SINGLE

Enrollment

190

Conditions

Obstructive Sleep Apnea Central Sleep Apnea Mixed Sleep Apnea Cheyne-Stokes Respiration

Interventions

SomnaPatchDEVICE

SomnaPatch is a standalone flexible diagnostic skin-adhesive patch with electronics inside. The patch is placed on the patient's face.

PolysomnographyDEVICE

Polysomnography performed in a sleep lab is considered a gold standard in diagnosing the sleep breathing disorders.

Eligibility

Sex: ALLMin age: 20 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Able to understand and sign the informed consent * Able to comply with visits and follow ups included in this protocol * Ages 20-85 years Exclusion Criteria: * An unstable medical condition, acute or chronic, that in the opinion of the investigator puts the subject at health risks related this trial or interferes with the clinical trial and data collection. * Skin rash on the nose or on the maxillary area. * A history of skin allergy to medical tape, and hypoallergenic tapes. * A history of skin cancer on the nose or on the maxillary area. * A history of the base of skull fractures, facial fractures

Locations (3)

Preferred Research Partners, Inc

Little Rock, Arkansas, United States

Peninsula Sleep Center

Burlingame, California, United States

The Good Sheperd Sleep Center, LLC

Tampa, Florida, United States

Outcomes

Primary Outcomes

Agreement Between Polysomnography (PSG) and SomnaPatch in Detecting Patients Apnea-Hypopnea Index (AHI)

AHI is the number of apneas and hypopneas that occur over an hour during the course of the night. The SomnaPatch and PSG were wore simultaneously over the night. The results from the SomnaPatch and PSG were compared per individual for agreement

Time frame: 1 night

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.